Cook Medical, Ambu A/S to jointly address endoscope-related infections
Category: #health  By Pankaj Singh  Date: 2019-05-20
  • share
  • Twitter
  • Facebook
  • LinkedIn

Cook Medical, Ambu A/S to jointly address endoscope-related infections

The two firms will bring forth single-use endoscopes to patients undergoing ERCP procedures to reduce the risk associated with serious cross-contaminations.

Medical device company, Cook Medical Incorporated has recently agreed to enter into a partnership with Ambu A/S, under which it will supply Ambu’s disposable, single-use duodenoscope in the U.S., following an FDA clearance. According to sources, the scope currently being developed by Ambu will help in addressing infections triggered by cross-contamination.

For the uninitiated, U.S. regulatory authorities, since 2015, have intensified their focus on cross-contamination in endoscope, particularly on reusable endoscopes used for gastrointestinal procedures, as it poses a contamination risk to patients mostly due to being more difficult to reprocess between uses.

However, as single-use scopes do not require cleaning or repair, it is likely that they will have a significant impact on device-related infections and improve hospital workflows, cite reports.

According to a statement, Barry Slowey, VP, Endoscopy business, Cook Medical, said that the firm aims on improving patient care and is seeking ways to reduce the risk of infections associated with the use of reusable endoscopes. He said that the collaboration with Ambu is based on a shared goal to enhance patient safety.

Juan Jose Gonzalez, CEO, Ambu, said that the partnership marks a major milestone towards the firm’s vision of developing a single-use ERCP solution, adding that the company, in conjunction with Cook Medical, plans on bringing single-use endoscopes to patients undertaking ERCP procedures to reduce the risk associated with serious cross-contaminations.

Founded in 1963, Cook Medical has closely worked with doctors to develop technologies that prevent the necessity for open surgery. Presently, the company is combining biologic materials, medical devices, and cellular therapies to help the world’s healthcare systems offer better outcomes more efficiently. 

In the meantime, Ambu is presently seeking regulatory clearance from the United States FDA for the single use duodenoscope developed by the company. The products are expected to be released in the U.S. prior to the end of 2020.

Source Credit: https://www.businesswire.com/news/home/20190518005026/en/Cook-Medical-Ambu-Announce-Collaboration-Address-Endoscope-Related

https://www.cookmedical.com/newsroom/cook-medical-ambu-announce-collaboration/

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Pankaj Singh    

Pankaj Singh

With an experience as an insurance underwriter and a freelance writer under his belt, Pankaj Singh boasts of quite some expertise in the field of content creation. A qualified Post Graduate in Management, Pankaj has also completed a detailed course in Digital Marketin...

Read More

More News By Pankaj Singh

Yumanity starts Phase 1 trial of YTX-7739 to treat Parkinson’s disease
Yumanity starts Phase 1 trial of YTX-7739 to treat Parkinson’s disease
By Pankaj Singh

Number of cases where people are affected with neurodegenerative diseases have been growing at a substantial pace. Alzheimer’s disease and Parkinson’s disease are the most common neurodegenerative diseases found across the world. Various ...

AngioDynamics buys Eximo Medical and its 355nm Laser Atherectomy tech
AngioDynamics buys Eximo Medical and its 355nm Laser Atherectomy tech
By Pankaj Singh

Owing to widescale tobacco use, the world is seeing an increased number of cancer and vascular diseases. India alone registers more than 10 million cases of peripheral artery disease on an annual basis. Technology and healthcare enterprises are incre...

Scholar Rock to showcase preclinical, phase 1 clinical data of SRK-015
Scholar Rock to showcase preclinical, phase 1 clinical data of SRK-015
By Pankaj Singh

SMA is a rare genetic disease that typically affects young children. Currently, there is no cure for spinal muscular atrophy (SMA), however, various pharmaceutical firms across the world are working to discover a novel, innovative treatment for the d...